Monash IVF Group Limited

CHIA:MVF Stock Report

Market Cap: AU$259.1m

Monash IVF Group Valuation

Is MVF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of MVF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: MVF (A$0.66) is trading below our estimate of future cash flow value (A$2.59)

Significantly Below Future Cash Flow Value: MVF is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MVF?

Key metric: As MVF is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MVF. This is calculated by dividing MVF's market cap by their current earnings.
What is MVF's PE Ratio?
PE Ratio17.1x
EarningsAU$15.16m
Market CapAU$259.11m

Price to Earnings Ratio vs Peers

How does MVF's PE Ratio compare to its peers?

The above table shows the PE ratio for MVF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.7x
REG Regis Healthcare
53.9x22.23%AU$2.0b
RHC Ramsay Health Care
37.5x18.83%AU$10.1b
ACL Australian Clinical Labs
15.9x15.42%AU$421.1m
CGS Cogstate
23.5x23.32%AU$373.1m
MVF Monash IVF Group
17.1x17.10%AU$259.1m

Price-To-Earnings vs Peers: MVF is good value based on its Price-To-Earnings Ratio (17.1x) compared to the peer average (32.7x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does MVF's PE Ratio compare vs other companies in the Oceanian Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
MVF 17.1xIndustry Avg. 19.5xNo. of Companies4PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MVF is good value based on its Price-To-Earnings Ratio (17.1x) compared to the Global Healthcare industry average (18.9x).

Price to Earnings Ratio vs Fair Ratio

What is MVF's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MVF PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.1x
Fair PE Ratio22.7x

Price-To-Earnings vs Fair Ratio: MVF is good value based on its Price-To-Earnings Ratio (17.1x) compared to the estimated Fair Price-To-Earnings Ratio (22.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MVF forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.66
AU$0.83
+25.25%
12.85%AU$1.00AU$0.69n/a6
Feb ’27AU$0.71
AU$0.83
+16.71%
13.61%AU$0.95AU$0.65n/a6
Jan ’27AU$0.73
AU$0.80
+9.34%
12.31%AU$0.95AU$0.65n/a6
Dec ’26AU$0.86
AU$0.82
-4.29%
12.54%AU$0.95AU$0.65n/a7
Nov ’26AU$0.69
AU$0.86
+26.21%
12.31%AU$1.00AU$0.72n/a7
Oct ’26AU$0.69
AU$0.86
+24.39%
12.31%AU$1.00AU$0.72n/a7
Sep ’26AU$0.70
AU$0.86
+22.63%
12.31%AU$1.00AU$0.72n/a7
Aug ’26AU$0.80
AU$1.07
+34.75%
16.34%AU$1.30AU$0.75n/a7
Jul ’26AU$0.71
AU$1.10
+53.85%
11.40%AU$1.30AU$0.95n/a7
Jun ’26AU$0.77
AU$1.14
+48.42%
10.31%AU$1.30AU$1.00n/a7
May ’26AU$0.84
AU$1.31
+55.95%
13.47%AU$1.60AU$1.09n/a7
Apr ’26AU$1.13
AU$1.52
+35.49%
10.79%AU$1.75AU$1.25n/a7
Mar ’26AU$1.22
AU$1.52
+24.94%
10.79%AU$1.75AU$1.25AU$0.697
Feb ’26AU$1.20
AU$1.49
+24.57%
9.21%AU$1.75AU$1.25AU$0.717
Jan ’26AU$1.28
AU$1.47
+14.55%
6.31%AU$1.56AU$1.25AU$0.737
Dec ’25AU$1.20
AU$1.47
+22.70%
6.31%AU$1.56AU$1.25AU$0.867
Nov ’25AU$1.18
AU$1.52
+28.95%
10.77%AU$1.85AU$1.25AU$0.697
Oct ’25AU$1.25
AU$1.49
+19.89%
11.48%AU$1.85AU$1.25AU$0.698
Sep ’25AU$1.21
AU$1.49
+23.61%
11.48%AU$1.85AU$1.25AU$0.708
Aug ’25AU$1.38
AU$1.56
+13.48%
8.83%AU$1.75AU$1.29AU$0.807
Jul ’25AU$1.25
AU$1.54
+23.76%
7.45%AU$1.70AU$1.29AU$0.718
Jun ’25AU$1.43
AU$1.54
+8.13%
7.45%AU$1.70AU$1.29AU$0.778
May ’25AU$1.46
AU$1.54
+5.90%
7.45%AU$1.70AU$1.29AU$0.848
Apr ’25AU$1.45
AU$1.53
+5.73%
8.17%AU$1.70AU$1.29AU$1.137
Mar ’25AU$1.45
AU$1.57
+8.47%
5.41%AU$1.70AU$1.45AU$1.226
AU$0.82
Fair Value
19.6% undervalued intrinsic discount
6
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/05 14:06
End of Day Share Price 2026/03/05 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monash IVF Group Limited is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bradley WatsonBell Potter
Martyn JacobsBell Potter
Tara SperanzaBell Potter